Optimizing Workflow for OncotypeDX Result Turnaround Time at a Safety Net Hospital
{{output}}
Introduction: The OncotypeDX test for patients with breast cancer with early-stage, hormone-receptor-positive, HER2-negative disease can predict the benefit of adjuvant chemotherapy in addition to hormone therapy. Delivering Onco... ...
